Bladder Cancer: Blood in Urine, Cystoscopy, and Treatment

Bladder cancer often begins with painless blood in the urine, a symptom that should always be assessed by a doctor. Diagnosis commonly involves cystoscopy and tissue sampling, and treatment depends on the tumor type, stage, grade, and the person’s overall health.

Overview

Bladder cancer is a disease in which abnormal cells grow in the bladder, the hollow organ that stores urine before it leaves the body. Most bladder cancers begin in the urothelial cells, which form the inner lining of the bladder and other parts of the urinary tract. Because the bladder lining is in direct contact with urine, changes in urine appearance, especially blood in the urine, can be an important early clue.

The condition is commonly grouped into non-muscle-invasive and muscle-invasive bladder cancer. Non-muscle-invasive tumors remain in the inner layers of the bladder wall and are often treated through the urethra using an instrument called a cystoscope. Muscle-invasive tumors have grown into the bladder muscle and usually require more intensive treatment planning.

Not every episode of blood in urine means cancer. Urinary tract infections, kidney stones, prostate conditions, vigorous exercise, and certain medications can also cause hematuria. However, because bladder cancer can present without pain or other obvious symptoms, medical evaluation is important rather than waiting for the symptom to disappear.

Symptoms: Blood in Urine and Other Signs

The most common symptom of bladder cancer is hematuria, which means blood in the urine. It may be visible, making urine look pink, red, brown, or tea-colored, or it may be microscopic and found only on a urine test. In many people, the bleeding is painless and may come and go, which can make it easy to overlook.

Other urinary symptoms can include needing to urinate more often, a sudden urge to urinate, discomfort or burning during urination, or feeling that the bladder does not empty completely. These symptoms are not specific to bladder cancer and are often caused by infection or inflammation. Still, persistent, recurrent, or unexplained symptoms should be checked by a healthcare professional.

More advanced bladder cancer may cause pelvic pain, back or flank pain, difficulty urinating, unexplained weight loss, fatigue, or swelling in the legs. These symptoms can occur for many reasons, but they warrant prompt medical assessment. A doctor can decide which tests are needed based on symptoms, examination, and risk factors.

Causes and Risk Factors

Bladder cancer develops when genetic changes allow bladder cells to grow and divide in an uncontrolled way. In many cases, one single cause cannot be identified. Risk is influenced by a combination of environmental exposures, lifestyle factors, age, and individual biology.

Smoking is one of the most important known risk factors because chemicals from tobacco smoke can be filtered by the kidneys and stored in urine, where they contact the bladder lining. Occupational exposure to certain industrial chemicals, such as those historically used in dye, rubber, leather, paint, and metal industries, can also increase risk. Following workplace safety guidelines and using protective measures are important for people with potential exposure.

Other risk factors may include increasing age, being male, a personal history of bladder cancer, long-term bladder irritation, certain inherited conditions, previous pelvic radiation therapy, and some prior cancer treatments. Chronic urinary infections or long-term catheter use may be linked with specific types of bladder cancer in some settings. Having a risk factor does not mean a person will develop bladder cancer, and some people diagnosed have no obvious risk factors.

Diagnosis: Urine Tests, Cystoscopy, and Biopsy

Evaluation usually begins with a medical history, physical examination, and urine testing. A urinalysis can confirm whether blood is present, and urine culture may be used if infection is suspected. Urine cytology or other urine-based tests may look for abnormal cells or markers, but they do not replace direct examination of the bladder when cancer is a concern.

Cystoscopy is a central test for diagnosing bladder cancer. During cystoscopy, a urologist passes a thin camera through the urethra into the bladder to inspect the lining. Flexible cystoscopy may be done for initial evaluation, while a rigid cystoscope is often used in the operating room if tissue removal or a larger biopsy is needed.

If a suspicious area is seen, the doctor may perform a transurethral resection of bladder tumor, often called TURBT. This procedure removes visible tumor tissue through the urethra and provides samples for pathology. The pathology report identifies the cancer type, grade, and depth of invasion, which are essential for staging and treatment decisions.

Imaging tests may also be recommended. Ultrasound, CT urography, MRI, or other scans can help evaluate the kidneys, ureters, bladder wall, lymph nodes, and other organs when needed. The exact workup depends on the patient’s symptoms, kidney function, findings on cystoscopy, and whether the tumor appears non-muscle-invasive or muscle-invasive.

Staging and Grading: Why They Matter

Staging describes how deeply the tumor has grown and whether it has spread beyond the bladder. Non-muscle-invasive bladder cancer is limited to the inner lining or nearby connective tissue and has not entered the muscle layer. Muscle-invasive bladder cancer has grown into the bladder muscle and may have a higher chance of spreading to lymph nodes or other organs.

Grading describes how abnormal the cancer cells look under the microscope. Low-grade tumors tend to grow more slowly, while high-grade tumors are more likely to recur or progress. Both stage and grade guide treatment intensity and follow-up schedules.

Doctors also consider tumor size, number of tumors, previous recurrences, presence of carcinoma in situ, and whether the tumor was completely removed during TURBT. These details help estimate the risk of recurrence and progression. Treatment plans are individualized and may be discussed by a multidisciplinary team including urology, medical oncology, radiation oncology, radiology, pathology, and specialist nursing.

Treatment Options

Treatment depends on whether the bladder cancer is non-muscle-invasive, muscle-invasive, or advanced, as well as the person’s general health and preferences. For many non-muscle-invasive tumors, TURBT is the first treatment and may remove the visible tumor completely. After TURBT, some patients receive medication placed directly into the bladder, called intravesical therapy, to reduce the risk of recurrence or progression.

Intravesical therapy may include chemotherapy medicines or immunotherapy such as BCG, depending on risk category and availability. These medicines are delivered into the bladder through a catheter and are intended to act mainly on the bladder lining. Follow-up cystoscopies are important because bladder cancer can recur even after successful initial treatment.

Muscle-invasive bladder cancer often requires a broader approach. Options may include radical cystectomy, which removes the bladder and nearby lymph nodes, sometimes combined with chemotherapy before or after surgery. When the bladder is removed, the surgeon creates a new way for urine to leave the body, such as an ileal conduit or, in selected patients, a continent urinary diversion or neobladder.

For some patients, bladder-preserving treatment may be considered, often combining maximal TURBT, radiation therapy, and chemotherapy. Advanced or metastatic bladder cancer may be treated with systemic therapies such as chemotherapy, immunotherapy, antibody-drug conjugates, or targeted therapy when appropriate based on tumor features. The benefits and side effects of each option should be discussed carefully with the treating team.

Prevention, Self-Care, and Follow-Up

There is no guaranteed way to prevent bladder cancer, but some steps may reduce risk. Avoiding tobacco is one of the most meaningful measures; people who smoke can ask a doctor about evidence-based support to quit. In workplaces with chemical exposure, using protective equipment and following occupational safety rules can help limit contact with harmful substances.

Staying well hydrated, eating a balanced diet rich in fruits and vegetables, and seeking treatment for persistent urinary symptoms support overall urinary health. People should not assume that recurrent blood in urine is due to infection without appropriate evaluation, especially if urine cultures are negative or symptoms keep returning. Any supplement or alternative therapy should be discussed with a clinician to avoid interactions with cancer treatments.

Follow-up after bladder cancer treatment is an essential part of care. Surveillance may include repeated cystoscopy, urine tests, imaging, and assessment of urinary function and quality of life. The schedule varies by risk level and treatment type, and patients are encouraged to keep appointments even when they feel well.

When to See a Doctor

A person should seek medical advice for any visible blood in the urine, even if it happens only once and there is no pain. Medical evaluation is also important for persistent burning, frequent urination, urgency, pelvic pain, or unexplained urinary changes. Early assessment helps identify common causes such as infection or stones and also ensures that more serious causes are not missed.

Urgent care may be needed if a person cannot pass urine, passes large blood clots, has fever with flank pain, severe pain, or feels very unwell. People already diagnosed with bladder cancer should contact their care team if they develop new bleeding, difficulty urinating, worsening pain, or side effects from treatment. Clear communication helps clinicians adjust care safely.

International patients who need evaluation or treatment can be assessed by qualified urology and oncology teams. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat bladder cancer for international patients, including cystoscopy, pathology, imaging, surgery, and oncology care when appropriate.

Frequently asked questions

Does blood in urine always mean bladder cancer?

No. Blood in urine can be caused by urinary tract infection, kidney stones, prostate enlargement, kidney disease, exercise, medications, or other conditions. However, visible blood in urine should always be evaluated by a doctor because bladder cancer is one possible cause.

Is cystoscopy painful?

Many people tolerate flexible cystoscopy well with local anesthetic gel, although they may feel pressure or mild discomfort. Some burning with urination or a small amount of blood can occur afterward. The healthcare team explains what to expect and when to report symptoms such as fever, heavy bleeding, or inability to urinate.

What is TURBT in bladder cancer care?

TURBT stands for transurethral resection of bladder tumor. It is a procedure in which the doctor removes visible tumor tissue through the urethra using a cystoscope, without an external incision. TURBT is both diagnostic and therapeutic because it provides tissue for pathology and can remove non-muscle-invasive tumors.

Can bladder cancer come back after treatment?

Yes, bladder cancer can recur, especially in the bladder lining after treatment for non-muscle-invasive disease. This is why regular follow-up cystoscopy and urine testing may be recommended. The follow-up schedule depends on the tumor’s stage, grade, and risk features.

Will everyone with bladder cancer need bladder removal surgery?

No. Many people with non-muscle-invasive bladder cancer are treated with TURBT and, when needed, intravesical therapy. Bladder removal surgery is more commonly considered for muscle-invasive disease, very high-risk non-muscle-invasive disease, or cancer that does not respond to certain treatments. Decisions are individualized after careful discussion.

What lifestyle changes are helpful after a bladder cancer diagnosis?

Stopping smoking, attending all follow-up appointments, maintaining hydration, and reporting new urinary symptoms promptly are important steps. A balanced diet, regular physical activity as tolerated, and managing treatment side effects with the care team can support overall health. Lifestyle measures complement medical treatment but do not replace it.

References

• European Association of Urology
• American Cancer Society
• National Cancer Institute
• European Society for Medical Oncology
• World Health Organization

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.